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Abstract
Background: Phage display is a platform for selection of specific binding molecules and this is a clear-cut motivation for
increasing its performance. Polypeptides are normally displayed as fusions to the major coat protein VIII (pVIII), or the minor
coat protein III (pIII). Display on other coat proteins such as pVII allows for display of heterologous peptide sequences on the
virions in addition to those displayed on pIII and pVIII. In addition, pVII display is an alternative to pIII or pVIII display.
Methodology/Principal Findings: Here we demonstrate how standard pIII or pVIII display phagemids are complemented
with a helper phage which supports production of virions that are tagged with octa FLAG, HIS6 or AviTag on pVII. The
periplasmic signal sequence required for pIII and pVIII display, and which has been added to pVII in earlier studies, is
omitted altogether.
Conclusions/Significance: Tagging on pVII is an important and very useful add-on feature to standard pIII and pVII display.
Any phagemid bearing a protein of interest on either pIII or pVIII can be tagged with any of the tags depending simply on
choice of helper phage. We show in this paper how such tags may be utilized for immobilization and separation as well as
purification and detection of monoclonal and polyclonal phage populations.
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Introduction
Phagedisplayisaplatformforselectionofbinderswithaffinityfor
specific target molecules, and also exhibits high versatility with
respect to target discovery [1]. In both cases, libraries of
polypeptides are created as fusions to phage coat proteins that are
solventexposed [2,3].Thewtfilamentousphage virionsM13, fdand
f1 have about 2,700 copies of the major coat protein pVIII, and in
addition, express approximately 3–5 copies each of pIII, pVI, pVII
and pIX; pIII and pVI on one virion tip and pVII and pIX on the
other [4]. Polypeptides have been fused to and displayed on all five
structural proteins, but only pIII and pVIII display have gained
widespread use. With the exception of pVI display, which has been
evaluated for use with cDNA libraries [5], it is common to the
majority of phage display protocols that the heterologous peptide is
placed in-frame between an N-terminal signal sequence and the
mature form of the viral capsid protein. Alternatively, the
heterologous peptide can be combined with a modified version of
pIII in the periplasm, but both components are still dependent on
signal sequence-directed periplasmic targeting [6,7].
Fusion coat proteins may be encoded either in a phage genome
or by a phagemid, and in the latter case, complementation by a
helper phage is needed to support virion production.
It is also possible to combine multiple display of more than one
type of fusion protein per virion by using both genome-based
vectors [8,9,10,11,12] and phagemid systems [13]. The resulting
bifunctional phage particles have been utilized in a number of
areas such as life sciences [9], as therapeutics [8,10,11] and in solid
state material sciences [12,13].
Since pVII, like pIII, is found at the virion tip in 3–5 copies,
peptide display on pVII might be an attractive alternative to pIII
display,andindeed,genomicpVIIdisplayhasbeenreported[14].In
thatstudy,an N-terminalsignal sequencetargeting the fusionprotein
to the periplasm was held as a component critical for successful
display. However, of the five structural capsid proteins that build the
filamentous phage virion, only pIII and pVIII are synthesized as
precursors containing N-terminal signal sequences [4].
Here, for the first time we demonstrate that signal sequence
directed periplasmic targeting of the fusion is not necessary for
functional pVII display. We explore display through pVII and
engineer helper phage genomes that combined with standard pIII
or pVIII phagemid display support the production of bispecific
virions. Defined tags were added to virions with pIII or pVIII
fusions. Thus, we used the modified helper phages to effectively
FLAG-, HIS6- and AviTag-tag phage particles with pIII or pVIII
phagemid-encoded fusions. We also show pIII/pVII phage-
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e14702genome double display. Thus, we make existing phage display
technology easily compatible with an extensive molecular biology
tool box for immobilization, purification and detection.
Results
M13 Helper Phages with Tags Fused to pVII
A series of mutants were constructed based on the two
genetically different, but functionally identical helper phage
genomes, M13K07 and VCSM13. We inserted either an octa-
FLAG, hexa-His (HIS6) or a BirA recognition sequence (AviTag)
N-terminally to the pVII open reading frame (ORF) such that the
critical single nucleotide spacing to the upstream pV ORF and the
start codon was maintained [15] (Fig. 1A). The M13K07 modified
helper phage genomes were then introduced into host cells,
propagated as normal helper phages and the culture supernatants
titered for phage content as kanamycin resistant colony forming
units (cfu
kanR), which was found to be comparable to the non-pVII
modified helper phage (Fig. S1A). Identical results were obtained
with the pVII modified VCSM13 (data not shown). We then tested
the modified M13K07 for their ability to rescue pIII display
phagemids encoding either a single chain Fv (scFv) or a single
chain T cell receptor (scTCR) [16]. The three pVII tagged helpers
performed essentially as the untagged helper. Thus, the phage
clearly tolerated peptides that differed in length, pI and charge
fused N-terminally to pVII (Fig. S1B - D). We then absorbed
virions to tag-specific supports (Fig. 1B-E). The AviTag-virions
were absorbed to streptavidin (SA) coated beads, and bound
virions detected by an anti-M13-HRP monoclonal antibody
(mAb). Initial experiments demonstrated inefficient virion capture,
presumably due to low endogenous BirA activity as the standard
phagemid packaging protocol is conducted at 30uC( data not shown).
This was overcome by making a new F
+ E. coli host strain,
AVB100FmkII, which over-expresses birA. Phagemid rescue using
this strain led to markedly improved SA-specific binding of the
virions (Fig. 1B, left part). Approximately 70% of the input phages
were captured on beads estimated by titering the phage content in
the waste (as cfu
ampR) after extensive washing of the bead-virion
complexes (Fig. 1B, right part). These data demonstrate that the
AviTag-pVII fusion is surface exposed and functional as a BirA
substrate. The FLAG-tagged phages bound strongly to two
different anti-FLAG mAbs, M2 and M5 (Fig. 1C). M5 binds the
FLAG peptide only when located at an unprocessed N-terminus,
and the strongest reactivity was seen with M5, nearly reaching the
Figure 1. pVII tag-modified helper phages are structurally and functionally identical to normal helper phages, and donate a
defined phenotype to pVII. (A) Schematic illustration of the pV, pVII, pIX genomic junctions in the M13 genome framed by the unique BsrGI/SnaBI
RE sites. The three tag modifications, their site of insertion and physical characteristics are given. Isoelectric point (pI) as well as average charge (1)
was computed using ProtParam (http://ca.expasy.org/). (B) AviTag-pVII functionality as BirA substrate assessed by virion binding to magnetic SA
beads and detection with an anti-M13 Ab (BirA enzyme activity provided by E. coli XL1-Blue or AVB100FmkII). (C) FLAG-pVII functionality as assessed
by virion binding to immobilized anti-FLAG M2 and M5 mAbs and detection with anti-M13 Ab. (D) HIS6-pVII functionality assessed by virion binding
to magnetic IMAC beads and detection with an anti-M13 Ab. Virion binding to the beads was done without (gray bars) or with (black bar) 300 mM
imidazole in the binding buffer. (E) HIS6-pVII functionality assessed as in D, employing HIS6-pVII tagged pVIII phagemid display (pGALD8mFN,
unpublished) virions (left part). Specific IMAC bead capture efficiency assessed by titration of imidazole-eluted pVIII phagemid virions after bead
capture, shown as percent of in-put (% recovery=out-put (cfu
ampR)/in-put (cfu
ampR)6100), right part.
doi:10.1371/journal.pone.0014702.g001
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was surprising, since phages contain thousands of pVIII epitopes
and a maximum of only five pVII-FLAG epitopes. Thus, the
observed binding clearly underscores strong and specific M5
phage absorption. The HIS6-tagged virions bound IMAC matrix
beads in a pH dependent manner (Fig. S2), and the binding could
be specifically abolished using imidazole (Fig. 1D). Increasing the
spacer length between pVII and the HIS6-tag did not increase the
efficiency of bead capture (Fig. S2). Moreover, similar IMAC bead
capture properties was also seen with pVIII display phagemid
virions rescued using this HIS6-pVII helper phage system (Fig. 1E,
left part), and based on the in-put to out-put titers after elution,
there was a 150-fold differential recovery depending on the
absence or presence of the HIS6-modification (Fig. 1E, right part).
Imaging analysis by electron microscopy showed that the pVII
modified virions were morphologically identical to the unmodified
virions (data not shown), ruling out that the pVII modification
introduces any gross physical alterations of the virions as
compared to their unmodified counterparts.
pVII-tagging differentiate mixed virion populations
The ability to produce distinct virion populations with different
pVII tags may allow their physical separation from complex
mixtures. As proof of concept, we blended a small amount of E. coli
AVB100FmkII in vivo biotinylated AviTag-virions into a large
amount of untagged ‘‘background‘‘ virions. We then did a single
SA bead capture, and the bead-virion complexes used for direct
infection of fresh host cells after extensive washing. We found that
the procedure led to a 5610
3 fold enrichment of tagged virions
with an untagged background of 0.002% (Fig. 2).
Bispecific multivalent pIII and pVII display
The results above clearly show that bispecific phages are
obtained by the combined use of pIII (phagemid encoded) and
pVII (helper phage encoded) display. To test whether virions are
assembled when pIII and pVII fusions are encoded within the
same phage genome, we introduced the AviTag-pVII modification
and the scTCR-pIII fusion into fUSE5 [17], thereby creating the
bispecific pIII-pVII phage genome display vector f37
AviTag.
Functional display on both distal tips of the virions was indeed
demonstrated (Fig. S3).
Discussion
Heterologous peptide display on pIII or pVIII is based on signal
sequence dependent translocation of the fusion from cytosol to the
periplasm. Here, we show efficient display on another capsid
protein, namely pVII. In contrast to earlier reports, this was
achieved without leader mediated periplasmic targeting of the
fusion [14,18]. Despite the fact that the pVII protein lacks any
known signal sequence, it is yet inserted into and spans the inner
membrane prior to virion incorporation without post-translational
processing [4,19]. Although the mechanism of both wt and
modified pVII membrane insertion is unknown, the lack of a signal
sequence signature suggests a different transport route than either
of the SRP-, SEC, TatABC or YidC-dependent pathways of the
E. coli secretory machinery [20]. The discrepancy between the
current and an earlier report regarding the feasibility of genomic
pVII fusion protein display without an N-terminal leader sequence
may at least partly be due to the nature of the chosen fusion
protein [19]. The former study used glutathione-S-transferase,
which is a globular protein that readily folds and dimerizes in the
cytosol, which may have hampered periplasmic targeting [21].
The lack of an N-terminal leader sequence may alleviate
unpredictable heterogeneity in functional peptide display due to
incomplete or lack of leader peptidase signal sequence cleavage
[22].
All three pVII-tag fusions reported herein were encoded on
helper phage genomes, which in turn were used to support
production of virions with heterologous fusions to pIII or pVIII
encoded on phagemids. Thus, the resulting virions displayed a tag
on pVII as well as larger fusions on pIII or pVIII. In contrast to
earlier reports on bispecific display that requires reformatting to
new dedicated vectors, these novel helper phages significantly
improves the versatility and ease of use with existing systems
[8,9,13,18]. Any pIII or pVIII display phagemid encoding single
clones or a library can be used with one of the pVII modified
helper phages described, and bispecific display with a pVII-tag of
choice is obtained after standard phagemid rescue. Importantly,
the tag on pVII does not interfere with the function of the other
fusion. Furthermore, the tag-peptides reported herein, namely
AviTag, FLAG and HIS6, which are among the most commonly
used tags for detection, immobilization and purification, may be
very easily exchanged with another tag of interest in a quick helper
phage mutagenesis step. As a very high affinity SA tag, AviTag was
chosen, rather than alternatives such as the Strep-tag, despite its
need for enzymatic modification to gain functionality. This
potentially labor intensive step was easily integrated into the
normal phage propagation cycle merely by exploiting an F positive
version of the birA over-expressing E. coli strain AVB100. In vivo
biotinylation of the virion was thereby achieved without adding
extra processing steps.
In the examples above, the pIII and pVII fusions are found on
separate genetic elements (a phagemid and a helper phage
genome); hence only low valence pIII is achieved. Using the
genome display vector f37, we also show that pIII and pVII fusions
are equally well tolerated when encoded in the same vector
rendering multivalent bispecific display. This genomic system also
offers the potential advantage of simplifying and speeding up the
turn over time during propagation as no helper phage super
Figure 2. Tag-pVII mediated enrichment of virions. In vivo
biotinylated phagemid (ampR) virions displaying a scTCR on pIII and
AviTag on pVII were spiked into VCSM13 helper phage (kanR) at a ratio
of approximately 3610
25. After a single round of SA bead capture and
extensive washing, the amount of phagemid (cfu
ampR) and helper
phage (cfu
kanR) virions captured were determined using the beads for
direct infection as described in Methods. The results are shown as
percent of in-put retrieved (NA, not applicable).
doi:10.1371/journal.pone.0014702.g002
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processing steps are needed.
Finally, we show that one virion population can be retrieved
after mixing with a different virion population, using the pVII
fusion tag. Importantly, the separation of the virion particles takes
place in solution before any selective propagation step. Differential
tagging of e.g. two separate pIII libraries would allow library
against library selection [23] and physically distinguish between
two (or more) populations of virions independently of their POIs
displayed.
Although not explored here, it is highly conceivable that type 7
offers an attractive alternative to current type 3 display for
construction of and affinity selection from large peptide libraries
[24]. Since pIII is of particular importance for early events in
E. coli entry, a complete lack of infectivity interference is expected
when pIII is wt [25]. Indeed, in a direct comparison between
signal sequence-dependent genomic pIII and pVII display,
Kwasnikowski et al. reported superior antigen reactivity with pVII
display [14]. It may well be that signal sequence independent
peptide libraries offer an additional advantage due to lack of
heterogeneous leader peptidase processing [22]. An additional
advantage to pVII display, leaving pIII unaltered, is that virion
rescue following a library selection step may be performed without
breaking the virion-target bond, as elution may be done by
infection directly on the solid phase. Especially for retrieving high
affinity binders, when the strong virion-target interaction may be
resistant to a variety of elution strategies, this simplifies rescue and
may well increase the successful isolation of such binders [26].
In summary, we have demonstrated display of three peptide tags
on pVII that are up to 17 aa in length and have different charge
and pI. Hence, despite the large heterogeneity in the physio-
chemical properties between these three fusions, no apparent
influence on wt pVII function was observed. A summary of the
different phagemid and phage genome display methods are shown
in Figure 3. We believe this pVII-tagging approach by use of
modified helper phages will significantly expand the versatility of
existing pIII and pVIII display.
Materials and Methods
Plasmids, bacterial strains, phage and materials
The phOx-BSA and pSEX81 phagemid vector harboring a
phOx-BSA specific affinity matured human scFv was kindly
provided by Affitech Research AS (Oslo, Norway). The pSEX and
pFKPDN phagemids harboring the scTCR Vab4B2A1, as well as
the phage genome vectors fUSE5-scTCR Vab4B2A1 and pSC
have been described previously [16,27]. The E. coli strains K91K
(thi, lacZ
-:TnlNK1105 (Kan
r)) and MC1061 (hsdR mcrB araD139
D(araABC-leu)7679D(lac)174 galU galK strA thi) were obtained from
Dr. G. P. Smith (Division of Biological Sciences, University of
Missouri, USA). The E. coli strains XL1-Blue (recA1 endA1 gyrA96
thi-1 hsdR17 supE44 relA1 lac [F proAB lacI
qZDM15 Tn10 (Tet
r)]
and CJ236 (FD(HindIII)::cat (Tra+Pil+Cam
r)/ung-1 relA1 dut-1 thi-1
spoT1 mcrA) were purchased from Stratagene (LaJolla, CA, USA)
and New England Biolabs (Ipswich, MA, USA), respectively. The
E. coli MC1061-derived AVB100 strain that harbors an L-
arabinose inducible birA cassette was purchased from Avidity
LLC (Aurora, CO, USA). To obtain the F-positive AVB100FmkII
(Str
r/Tet
r), the AVB100 parent was mated with XL1-Blue using
standard methodology [2]. Likewise, the F-positive AVB100F
(Str
r/Cam
r) was obtained by mating of AVB100 with CJ236.
M13K07 and VCSM13 helper phages were purchased from GE
Healthcare (Uppsala, Sweden) and New England Biolabs (Ipswich,
MA, USA), respectively. All restriction enzymes (RE) were
purchased from New England Biolabs (Ipswich, MA, USA).
DNA oligos were purchased from MWG Biotech AG (Ebersberg,
Germany). Pfu Ultra and Phusion DNA polymerases were
purchased from Stratagene (LaJolla, CA, USA) and Sigma-Aldrich
(Oslo, Norway), respectively. The anti-M13-HRP Ab and anti-
FLAG M2 and M5 mAbs were purchased from GE Healtcare
(Uppsala, Sweden) and Sigma-Aldrich (Oslo, Norway), respective-
ly. The F23.2 mAb was a kind gift from Dr. Uwe D. Staerz
(Department of Medicine, National Jewish Medical and Research
Center, Denver, USA) and the GB113 mAb [28] was purified
from cell supernatant on protein G-sepharose (GE Healtcare,
Figure 3. Tag-pVII phage display routes. (A) The M13K07 helper phage modified with an N-terminal pVII tag assembles into virions displaying
the tag of choice on all 3–5 pVII copies on the virion tip. In principle, this modified helper phage genome is therefore analogous to a pIII phage
genome vector. (B) Used in phagemid rescue of any standard pIII phagemid in a 3+3 system, the Tag-pVII modified helper phage yields defined,
bispecific virions. Normally, such pIII phagemids render low valence display on pIII, whereas there will be multivalent Tag-pVII display. (C) Used in
phagemid rescue of any standard pVIII phagemid in an 8+8 system, the Tag-pVII modified helper phage yields bispecific display where all pVII carry
the tag, whereas the many thousand pVIII copies of the virion body will be a heterogeneous blend of POI-pVIII dispersed among wt pVIII. (D) When
the Tag-pVII modification is integrated into a pIII phage genome display vector, a system is made in which both virion tips are fully modified with a
fusion peptide on all copies of both pIII and pVII.
doi:10.1371/journal.pone.0014702.g003
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TM and MyOne
TM were
purchased from Invitrogen (Oslo, Norway). All media and buffers
were prepared essentially as described [29].
Design and construction of the pVII modified phage
genomes
Codon-optimized versions for prokaryotic expression of Avi-
Tag
TM (N-MSGLNDIFEAQKIEWHE-C), FLAG-tag (N-
MDYKDDDDK-C) and the HIS6-tag (N-MHHHHHH-C) pep-
tide sequences were attached 59-terminally to the pVII ORF in
M13K07 by QuikChange
TM in vitro mutagenesis according to the
manufacturers’ protocol (Stratagen, LaJolla, CA, USA). Primer
design was based on a DNA sequence alignment of M13K07,
VCSM13 and fUSE5 (Fig. S4). The modifications were verified by
DNA sequencing (in-house ABI lab DNA sequencing core facility,
Dept. Molecular Biosciences, University of Oslo). To ensure a
clean vector background, a BsrGI/SnaBI RE fragment containing
the modified pVII was moved into unmodified genomes on
compatible RE sites using standard techniques. The DNA
constructs were introduced into the E. coli hosts XL1-Blue or
MC1061 by electroporation. Primer sequences and GenBank
accession numbers for the resulting constructs are listed in
Table S1.
Virion production
Phagemid rescue from E. coli XL1-Blue using M13K07 or
VCSM13 helper phages was done essentially as described [30].
Recombinant phages were amplified from E. coli MC1061
transformed with fUSE5 essentially as described [31]. Phagemid
rescue in AVB100mkII and phage amplification in AVB100F were
done essentially as for XL1-Blue and MC1061, respectively, and
increased in vivo biotinylation was achieved by supplementing the
growth medium with 50 mM d-biotin and 0.4% w/v L-arabinose
(final concentrations). Virion assembly was monitored by spot
titration as described [25]. Where applicable, the virions were
purified and concentrated by PEG/NaCl precipitation as
described [32], and resuspended in PBS, pH 7.4. To estimate
the in vivo biotinylation level in AVB100mkII, the virions were 2x
PEG precipitated and captured on SA beads as described below.
The biotinylation level was then determined as 100-f, where f is the
fraction (in %) of virions in the waste of the in-put.
Phage capture ELISA and bead capture
In ELISA, the various targets (Abs and phOx-BSA) were
absorbed to MaxiSorp
TM microtiter plate wells (Nunc, Roskilde,
Denmark) in concentrations from 2.5 to 5 mg/ml in PBS, pH 7.4
overnight at 4uC. The wells were blocked with either PBSTM
(PBS supplemented with 0.05% v/v Tween 20 and 4% w/v skim
milk) or 2% w/v BSA (in PBS) for 1 h at room temperature (RT).
Virion preparations where then added and allowed to react for 1
to 2 h at RT, before captured virions were detected with anti-
M13-HRP (1:5,000) for 1 h at RT. The wells were developed with
ABTS substrate and the absorbance read at A405 nm. Alternatively,
the wells were developed with TMB soluble (Merck KGaA,
Darmstadt, Germany), stopped with 1M HCl, equilibrated and the
absorbance read at A450 nm.
For AviTag phage bead capture, 50 ml/tube MyOne
TM T1
beads were transferred to fresh 1.5-ml tubes and 500 ml 2% BSA
in PBS (w/v) was added. Likewise, 250 ml of virion containing
cleared supernatant were transferred to 1.5-ml tubes and
supplemented with 250 ml of 2% BSA. The tubes were then
incubated for 1 h at RT on a rotating wheel. Thereafter, the beads
were washed 3x by first immobilizing the beads by using a Dynal
tube magnet rack. The supernatant was discarded and 0.5 ml of
PBST (PBS supplemented with 0.05% Tween 20) added to each
tube. The tubes were taken out of the rack and briefly vortexed
before re-entered into the rack. The supernatant was again cleared
and the washing repeated twice. The tubes were removed from the
rack and 250 ml of blocked phage and 250 ml PBST were added to
each tube. The tubes were then incubated for 1.5 h/RT on a
rotating wheel. The tubes were washed 3x in PBST as described
above. 0.5 ml of PBST containing an anti-M13-HRP Ab (1:2000)
was then added to each tube and the tubes were incubated for
1 h/RT on a rotating wheel. The tubes were washed 3x in PBST
as described above. 500 ml TMB soluble was added and the
reaction stopped by an equal volume of 1M HCl after 5 min at
RT. 100 ml of each solution was transferred to Maxisorp ELISA
strips (Nunc, Roskilde, Denmark) and the absorbance measured at
A450 nm. For IMAC phage bead capture, 50 ml/sample TA-
LON
TM beads were prepared in Washing and Binding (WB)
buffer, either with pH 7 or 8, essentially as described by the
manufacturer. In one experiment, the WB buffer (pH 8) was
supplemented with 300 mM imidazole. The appropriate phage
samples were then added in a total volume of 500 ml (supernatant
or PEG precipitated) and incubated for 1 h/RT on a rotating
wheel. After washing the beads as described above using WB
buffer, anti-M13-HRP Ab (diluted 1:5000 in PBST) was added to
each tube and the tubes were further incubated 1 h/RT on a
rotating wheel. After washing in PBST, 500 ml TMB soluble was
added and the reaction stopped by an equal volume of 1M HCl
after 5 min at RT. 100 ml of each solution was transferred to
Maxisorp ELISA strips and the absorbance measured at A450 nm.
Supporting Information
Figure S1 Virion assembly and functionality analysis of pVII
modified helper phages. (A) Virion assembly efficiency in E. coli
XL1-Blue. Normal (denoted as wt) and pVII tag-modified
M13K07 helper phage production was assessed by infectious
titration, and values given as the number of kanamycin-resistant
(kanR) colony forming units (cfu) per ml culture supernatant. (B)
Phagemid rescue ability of normal and modified M13K07 helper
phages. Ampicillin-resistant (ampR) anti-phOx scFv- and scTCR-
pIII encoding phagemids were rescued and the virion production
capacity given as the number of cfuampR/ml by infectious
titration. (C) Phagemid (ampR) to helper phage (kanR) ratio in
infectious titration. (D) The integrity of the pIII displayed POI
(scFv anti-phOx or scTCR) on virions rescued with normal or the
modified M13K07 helper phages assessed by antigen-specific
phage capture ELISA. Briefly, phOx-BSA or the TCR surrogate
Ag mAb GB113 (the cognate Ag for the TCR is the murine
pMHC II complex I-Ed/l2315) was coated in microtiter wells and
interacting virions detected with an anti-M13 mAb as described in
Methods. Notably, the GB113 Ab is clonotypic for the 4B2A1
TCR from which the scTCR is derived [28].
Found at: doi:10.1371/journal.pone.0014702.s001 (0.28 MB TIF)
Figure S2 IMAC bead capture efficiency of HIS6-pVII virions
depend on tag-pVII spacer and pH during capture. (A) PEG
precipitated VCSM13 helper phage virions or pFKPDN-scTCR
4B2A1 phagemid-derived virions were prepared as described in
Methods. The bead capture was done as described by the
manufacturer protocol in the recommended sample volumes as
described in Methods. The Binding and Washing buffer was used
with either pH 7 or 8 and the virion in-put titer was normalized to
1x 1010/ml in PBS for all samples. Binding and subsequent
detection of captured virions were done with an anti-M13 Ab as
described in Methods. Two different HIS6-pVII modified helper
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latter has a 10 aa spacer between the HIS6-tag and the pVII
capsid protein (illustration in B). Both versions of the HIS6-
modified VCSM13 helper phage virions, but not the unmodified
(denoted wt), were captured on the IMAC beads. The HIS6
version bound with higher efficiency than the HIS6-GS2 version.
Moreover, virion capture was most efficient when done at pH 8.
The latter was also seen with phagemid-derived virions packaged
with the HIS6-pVII modified VCSM13 helper phage.
Found at: doi:10.1371/journal.pone.0014702.s002 (0.22 MB TIF)
Figure S3 Bispecific multivalent scTCR-pIII and AviTag-pVII
display encoded by a single phage genome. (A) Virion assembly
efficiency in E. coli MC1061 from fUSE5 (harboring a scTCR
4B2A1 pIII fusion) and its pVII tag-modified derivative f37Avi-
Tag. Numbers of tetracycline-resistant (tetR) cfu/ml in culture
supernatants and the corresponding PEG precipitated samples are
given as assessed by infectious titration in E. coli K91K. (B) The
integrity of the scTCR-pIII fusion on the virions assessed by
binding to conformation (F23.2) and TCR clonotypic (GB113)
mAbs in ELISA using titer normalized virion in-puts. (C) AviTag-
pVII functionality as endogenous BirA substrate (both E. coli
XL1-Blue (M13K07) and MC1061 (f37AviTag) assessed by virion
binding to magnetic SA beads detected by an anti-M13 Ab. (D)
Increased AviTag-pVII in vivo biotinylation is obtained with
f37AviTag using the E. coli AVB100F host strain (see Methods)
which over-expresses birA upon L-arabinose induction, as shown
by increased virion binding to magnetic SA beads detected by an
anti-M13 Ab.
Found at: doi:10.1371/journal.pone.0014702.s003 (0.52 MB TIF)
Figure S4 Multiple sequence alignment of the M13K07,
VCSM13 and fUSE5 genomes. The M13K07 (New England
Biolabs sequence), VCSM13 (GenBank accession no.: AY598820)
and fUSE5 (GenBank accession no.: AF218364) were aligned
using ClustalX 2.0.5 and manually annotated using GeneDoc
(http://www.psc.edu/biomed/genedoc). Only the relevant parts
of the genomes framed by the unique BsrGI and SnaBI RE sites
are shown together with the pV, pVII and pIX ORFs (only partial
ORFs for pV and pIX, respectively).
Found at: doi:10.1371/journal.pone.0014702.s004 (0.92 MB TIF)
Table S1 GenBank accession numbers and QuikChange
mutagenesis primers. The M13K07 (New England Biolabs
sequence: http://www.neb.com) and VCSM13 (GenBank acces-
sion no.: AY598820) is functionally identical both in their normal
and pVII-modified versions. Both genomes are 100% identical in
the BsrGI/SnaBI defined region where the pVII modification is
found. The pVII modifications use were made in the M13K07
genome and verified sequences shuffled into VCSM13 and fUSE5
(thereby creating f37) on the compatible BsrGI/SnaBI RE sites.
The sequences submitted to GenBank were based on the existing
VCSM13 and fUSE5 GenBank entries AY598820 and AF218364,
respectively.
Found at: doi:10.1371/journal.pone.0014702.s005 (0.06 MB
DOC)
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